DOI:
10.1055/s-00000102
Zeitschrift für Palliativmedizin
LinksClose Window
References
Ramalingam SS, Vansteenkiste J, Planchard D. et al.
Overall Survival with osimertinib in untreated, EGFR-mutated advanced NSCLC.
N Engl J Med 2020;
382: 41-50
DOI: 10.1056/NEJMoa1913662.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.